CUE
Price
$0.70
Change
+$0.01 (+1.45%)
Updated
Sep 26, 04:57 PM (EDT)
Capitalization
53.03M
41 days until earnings call
VRAX
Price
$0.61
Change
-$0.02 (-3.17%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.72M
Interact to see
Advertisement

CUE vs VRAX

Header iconCUE vs VRAX Comparison
Open Charts CUE vs VRAXBanner chart's image
Cue Biopharma
Price$0.70
Change+$0.01 (+1.45%)
Volume$200
Capitalization53.03M
Virax Biolabs Group
Price$0.61
Change-$0.02 (-3.17%)
VolumeN/A
Capitalization2.72M
CUE vs VRAX Comparison Chart in %
Loading...
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CUE vs. VRAX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Buy and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CUE: $0.69 vs. VRAX: $0.63)
Brand notoriety: CUE and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 95% vs. VRAX: 10%
Market capitalization -- CUE: $53.03M vs. VRAX: $2.72M
CUE [@Biotechnology] is valued at $53.03M. VRAX’s [@Biotechnology] market capitalization is $2.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, CUE is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 5 bullish TA indicator(s).

  • CUE’s TA Score: 4 bullish, 5 bearish.
  • VRAX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than CUE.

Price Growth

CUE (@Biotechnology) experienced а -5.48% price change this week, while VRAX (@Biotechnology) price change was -2.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +9.50%, and the average quarterly price growth was +52.01%.

Reported Earning Dates

CUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CUE($53M) has a higher market cap than VRAX($2.73M). CUE YTD gains are higher at: -36.688 vs. VRAX (-72.111). VRAX has higher annual earnings (EBITDA): -6.43M vs. CUE (-36.07M). CUE has more cash in the bank: 27.5M vs. VRAX (7.29M). VRAX has less debt than CUE: VRAX (380K) vs CUE (7.63M). CUE has higher revenues than VRAX: CUE (8.29M) vs VRAX (84.9K).
CUEVRAXCUE / VRAX
Capitalization53M2.73M1,945%
EBITDA-36.07M-6.43M561%
Gain YTD-36.688-72.11151%
P/E RatioN/AN/A-
Revenue8.29M84.9K9,760%
Total Cash27.5M7.29M377%
Total Debt7.63M380K2,009%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CUEVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTK14.321.00
+7.51%
Flotek Industries
CDT0.70N/A
-0.31%
CDT Equity Inc
FDS283.86-2.30
-0.80%
Factset Research Systems
KN23.13-0.23
-0.98%
KNOWLES Corp
ZENV1.41-0.04
-2.76%
Zenvia